GlobeNews Wire

Mandatory notice of shareholding 22 August 2025

August 22, 2025 13:00 ET  | Source: IDEX BIOMETRICS ASA Reference is made to IDEX Biometrics ASA’s disclosure on 21…

8 months ago

Financire de Tubize – Convening of the extraordinary general meeting of shareholders of Sep. 24, 2025

August 22, 2025 02:00 ET  | Source: Financière de Tubize SA Convening of the Extraordinary General Meeting of shareholders of…

8 months ago

Bavarian Nordic Announces First Half 2025 Results

COPENHAGEN, Denmark, August 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress…

8 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option

SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…

8 months ago

Order.co Named AI Procurement Software of the Year 2025 by CIOReview for Smart Sourcing and Fulfillment Innovation

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Order.co, a leading AI-powered procurement platform, today announced it has been named…

8 months ago

hololive English -Advent-s Talents Now Restyled as tokidoki Characters in HYTEs Newest Line of Products

tokidoki’s co-license brings exclusive designs to the Y70 PC chassis, along with matching keycaps, desk pad, and peripherals for PC…

8 months ago

SpaceEX Announces Official Entry into Emerging Markets such as Vietnam and the UAE, Further Expanding Global Presence

New York, USA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Global leading multi-asset trading platform SpaceEX has announced its official entry…

8 months ago

Advanz Pharma and Alvotech receive European approval for Mynzepli, Biosimilar to Eylea

Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular…

8 months ago

Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%

COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to…

8 months ago